Skip to main content
60°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Harmony Biosciences Holdings Inc
(NQ:
HRMY
)
36.36
+0.35 (+0.97%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Harmony Biosciences Holdings Inc
< Previous
1
2
3
4
5
6
7
Next >
Russell 2000 Front-Runners: 3 Stocks to Keep an Eye On
December 07, 2023
Although Russell 2000 stocks may operate in the lightweight category, these entities could potentially provide a knockout punch.
Via
InvestorPlace
Looking for growth without the hefty price tag? Consider NASDAQ:HRMY.
November 27, 2023
Investors seeking growth at a reasonable cost should explore HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY).
Via
Chartmill
NASDAQ:HRMY is probably undervalued for the fundamentals it is displaying.
November 22, 2023
HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
Via
Chartmill
While growth is established for NASDAQ:HRMY, the stock's valuation remains reasonable.
November 03, 2023
Investors should take note ofHARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY), a growth stock that remains attractively priced.
Via
Chartmill
Quick Look At Reports From ServiceNow, Chipotle, And Harmony
November 02, 2023
ServiceNow is a steady, reliable SaaS firm that continues to prove its value and growth potential to investors.
Via
Talk Markets
NASDAQ:HRMY is an undervalued gem with solid fundamentals.
November 01, 2023
For those who appreciate value investing, HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY) is a compelling option with its solid fundamentals.
Via
Chartmill
Harmony Biosciences's Earnings Outlook
October 30, 2023
Via
Benzinga
Analyst Ratings for Harmony Biosciences
October 16, 2023
Via
Benzinga
In the world of growth stocks, NASDAQ:HRMY shines as a value proposition.
October 12, 2023
NASDAQ:HRMY, a growth stock which is not overvalued.
Via
Chartmill
Harmony Biosciences (HRMY) Q3 2023 Earnings Call Transcript
October 31, 2023
HRMY earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
October 31, 2023
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Expert Ratings for Harmony Biosciences
September 25, 2023
Via
Benzinga
9 Analysts Have This to Say About Harmony Biosciences
September 07, 2023
Via
Benzinga
Expert Ratings for Harmony Biosciences
August 22, 2023
Via
Benzinga
Arista Networks, JinkoSolar, Repligen, Shutterstock And Other Big Stocks Moving Higher On Tuesday
October 31, 2023
U.S. stocks traded lower, with the Dow Jones falling more than 50 points on Tuesday. Here are some major stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Harmony Biosciences Reports Strong Third Quarter 2023 Financial Results
October 31, 2023
From
Harmony Biosciences
Via
GlobeNewswire
Why Harmony Biosciences Stock Is Trading Higher Today
October 16, 2023
Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) shares are trading higher on Monday as the stock rebounds after falling Friday on Phase 3 INTU
Via
Benzinga
Nasdaq Down Over 1%; Wells Fargo Beats Expectations
October 13, 2023
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 1% on Friday. The Dow traded down 0.02% to 33,622.97 while the NASDAQ fell 1.27% to 13,401.56. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Friday's Intraday Session
October 13, 2023
Via
Benzinga
Stocks Mixed Amid Earnings, Consumer Sentiment Data
October 13, 2023
Stocks are mixed this afternoon, as investors unpack earnings reports from several bank giants as well as economic data.
Via
Talk Markets
Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session
October 13, 2023
Gainers Sigma Additive Solutions, Inc. (NASDAQ: SASI) shares jumped 196% to $7.34 after the company announced the signing of a definitive agreement for the acquisition of NextTrip Holdings, Inc.
Via
Benzinga
Why Shares of Harmony Bioscience Are Falling on Friday
October 13, 2023
The company reported underwhelming phase 3 trial results for Pitolisant to treat idiopathic hypersomnia.
Via
The Motley Fool
Crude Oil Rises Sharply; Citigroup Posts Upbeat Earnings
October 13, 2023
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling over 1% on Friday. The Dow traded down 0.05% to 33,615.27 while the NASDAQ fell 1.22% to 13,409.29. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Is Sleep Disorder Related Harmony Biosciences Stock Trading Lower Today?
October 13, 2023
Harmony Biosciences Holdings Inc (NASDAQ: HRMY) announced topline results from the INTUNE Phase 3 study of pitolisant in patients with idiopathic hypersomnia (IH).
Via
Benzinga
New Possibilities For Cannabinoid Treatments: Acquisition To Transform Neuropsychiatric Disorder Therapies
October 11, 2023
Healthcare company Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) completed its previously announced acquisition of Zynerba Pharmaceuticals, Inc.
Via
Benzinga
2 Magnificent Growth Stocks to Buy Right Now
October 04, 2023
These two biotech stocks could be big winners for patient investors.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
September 25, 2023
Via
Benzinga
ZYNERBA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Zynerba Pharmaceuticals, Inc. - ZYNE
August 17, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023
September 07, 2023
Via
Benzinga
NASDAQ: HRMY Investor Alert: Investigation over Potential Wrongdoing at Harmony Biosciences Holdings, Inc.
August 17, 2023
San Diego, CA -- (SBWIRE) -- 08/17/2023 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Harmony Biosciences Holdings, Inc.
Via
SBWire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.